Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection

Jason V Baker, Jacqueline Neuhaus, Daniel Duprez, Lewis H Kuller, Russell Tracy, Waldo H Belloso, Stephane De Wit, Fraser Drummond, H Clifford Lane, Bruno Ledergerber, Jens Lundgren, Daniel E Nixon, Nicholas I Paton, James D Neaton, INSIGHT SMART Study Group

    138 Citationer (Scopus)

    Abstract

    Among a subgroup of participants in the Strategies for Management of Antiretroviral Therapy (SMART) Trial that were naïve to antiretroviral therapy (ART) or off ART (6 months or longer) at study entry, risk of AIDS and serious non-AIDS events were increased for participants who deferred ART compared with those randomized to (re)initiate ART immediately. Our objective was to determine whether ART initiation in this group reduced markers of inflammation and coagulation that have been associated with increased mortality risk in SMART. Changes in these biomarkers have been described after stopping ART, but not after starting ART in SMART.
    OriginalsprogEngelsk
    TidsskriftJ A I D S
    Vol/bind56
    Udgave nummer1
    Sider (fra-til)36-43
    Antal sider8
    ISSN1525-4135
    DOI
    StatusUdgivet - 1 jan. 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection'. Sammen danner de et unikt fingeraftryk.

    Citationsformater